去年，Embecta Corp表现最佳的业务板块Pen Needles实现营收784.10M美元。United States的营收贡献最高，去年达到579.10M美元。最近一个季度，截至2026-06-30，Embecta Corp表现最佳的业务板块Pen Needles实现营收177.50M美元。International的营收贡献最高，达到150.90M美元。

业务

营业收入

占比

年报

年报

单季报

Pen Needles

Safety

Syringes

Manufacturing Facility

Other

FY2025

Pen Needles

784.10M(72.57%)

Safety

137.80M(12.75%)

Syringes

124.60M(11.53%)

Manufacturing Facility

19.90M(1.84%)

Other

14.00M(1.30%)

地区

营业收入

占比

年报

年报

单季报

United States

International

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

579.10M(53.60%)

607.20M(54.06%)

601.40M(53.66%)

600.30M(53.15%)

609.00M(52.27%)

563.00M(51.84%)

570.00M(51.40%)

International

501.30M(46.40%)

515.90M(45.94%)

519.40M(46.34%)

529.20M(46.85%)

556.00M(47.73%)

523.00M(48.16%)

539.00M(48.60%)